Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype Fabienne GrieuWei Qi LiBarry Iacopetta Report Pages: 197 - 204
The 936C>T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake Gerald WolfReingard M. AignerPeter Krippl Report Pages: 205 - 208
Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients Winnie YeoWing M. HoPhilip J. Johnson Report Pages: 209 - 215
Association between the T27C polymorphism in the cytochrome P450 c17α (CYP17) gene and risk factors for breast cancer Chi-chen HongHenry J. ThompsonNorman F. Boyd Report Pages: 217 - 230
Integrin β3 Leu33Pro polymorphism and breast cancer risk: a population-based case-control study in Germany Shan Wang-gohrkeJenny Chang-claude Report Pages: 231 - 237
Increased frequency of long androgen receptor CAG repeats in male breast cancers Helen E. MacleanRobert W. BrownJeffrey D. Zajac Report Pages: 239 - 246
Effect of dietary glutamine on tumor glutathione levels and apoptosis-related proteins in DMBA-induced breast cancer of rats Valentina K. TodorovaStacy A. HarmsV. Suzanne Klimberg Report Pages: 247 - 256
Bone mineral density and adjuvant therapy in breast cancer survivors C. CrandallL. PetersenG. A. Greendale Report Pages: 257 - 261
Possible role of Stat5a in rat mammary gland carcinogenesis Liang ShanMinshu YuElizabeth G. Snyderwine Report Pages: 263 - 272
Central nervous system metastases in women after multimodality therapy for high risk breast cancer Lisa A. CareyMatthew G. EwendMark L. Graham Report Pages: 273 - 280
The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality Franklin G. Berger Commentary Pages: 281 - 285
Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients B. TarnowskiA. Chudecka-GłazI. Rzepka-górska Brief Communication Pages: 287 - 288
